Biotech China 2014
2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16)
Renaissance Toronto Hotel
1 Blue Jays Way
Toronto, Ontario
http://www.healthtech.com/2007/ctd/index.ASP
2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers 
Cambridge Healthtech Institute
Ontario Genomic Institute

Schedule of Presentations:

Monday, October 15, 2007
07:30:00 Registration & Morning Coffee (07:30-08:30)
08:30:00 OVERVIEW: Welcome to Toronto (08:30-08:40) Christian Burks
08:40:00 OVERVIEW: Chairperson’s Opening Remarks (08:40-08:45) Robert Phillips
08:45:00 Keynote Presentation (08:45-09:30) J Carl Barrett
09:30:00 Featured Presentation - Overview of Biomarkers: What Needs to be Done to Identify New Ones and Validate Them (09:30-10:00) Samir M. Hanash
10:00:00 Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs (10:00-10:30) Gary J. Kelloff
10:30:00 Poster Session, Exhibit Viewing and Coffee Break (10:30-11:10)
11:10:00 ADDRESSING THE VALIDATION BOTTLENECK (11:10-13:25) Henry Rodriguez, Brent Zanke, Robert Phillips, Paul Domanico
11:10:00 ADDRESSING THE VALIDATION BOTTLENECK: Chairperson’s Remarks (11:10-11:15) Peter DePhillips
11:15:00 ADDRESSING THE VALIDATION BOTTLENECK (Featured Speaker) Proteomic Technologies for Cancer Research: A Strategic Plan for Translating Discoveries to the Clinic (11:15-11:45) Featured Speaker Henry Rodriguez
11:45:00 ADDRESSING THE VALIDATION BOTTLENECK - A Fully Integrated Approach to Biomarker Discovery, Validation, and Screening: Is it Possible?(11:45-12:15) Paul Domanico
12:15:00 ADDRESSING THE VALIDATION BOTTLENECK: Luncheon Workshop - "Genotype-based Disease Risk Prediction. Are We Ready for Prime Time?" (12:15-13:25) Brent Zanke
13:25:00 CASE STUDIES - Biomarker Development from Validation to Clinical Implementation: Chairperson’s Remarks (13:25-13:30) Kenneth Evans
13:25:00 CASE STUDIES: Biomarker Development from Validation to Clinical Implementation (13:25-14:10) Ming-Sound Tsao, Geoffrey Liu, Kenneth Evans
13:30:00 CASE STUDIES - Predictive Biomarkers for Response to EGFR Therapy - Clinical Perspective: (13:30-13:50) Geoffrey Liu
13:30:00 CASE STUDIES - Predictive Biomarkers for Response to EGFR Therapy - Validation Perspective: (13:30-13:50) Ming-Sound Tsao
14:10:00 Question & Answer Session The Potential of Topoisomerase II Alpha Protein Overexpression (and Gene Alterations) as Predictive Markers in Breast Cancer (14:10-15:00) Kathleen I. Pritchard, Frances P. O'Malley
14:20:00 Question & Answer Session - The Potential of Topoisomerase II Alpha Protein Overexpression (and Gene Alterations) as Predictive Markers in Breast Cancer; Validation Perspective: (14:20-14:40) Frances P. O'Malley
14:40:00 Question & Answer Session - The Potential of Topoisomerase II Alpha Protein Overexpression (and Gene Alterations) as Predictive Markers in Breast Cancer; Clinical Perspective: (14:40-15:00) Kathleen I. Pritchard
15:00:00 Question & Answer Session (15:00-16:25) Andre T. Baron, Nita J. Maihle
15:10:00 Question & Answer Session: Poster Session, Exhibit Viewing, and Refreshment Break (15:10-15:45)
15:45:00 Question & Answer Session - Validation Perspective: (15:45-16:05) Nita J. Maihle
16:05:00 Question & Answer Session - Clinical Perspective: (16:05-16:25) Andre T. Baron
16:25:00 Question & Answer Session (16:25-16:30)
16:30:00 Technology Workshop (Sponsorship Available) (16:30-16:50)
16:50:00 Close of Session (16:50-17:00)
17:00:00 Buses depart for the MaRS Centre (17:00-17:30)
17:30:00 Evening Networking Reception at the MaRS Centre (17:30-19:00)
19:00:00 Buses return to Renaissance Hotel
Tuesday, October 16, 2007
08:00:00 BIOIMAGING FOR MONITORING RESPONSE TO THERAPY, DOSE SELECTION, ASSESSING MOLECULAR ACTIVITY AND RECEPTOR OCCUPANCY (08:00-13:30) Alex Valentin, Robert A. Comley, Walter P. Carney, Loretta McQuaid, Audrey Goddard, David Lester
08:00:00 Chairperson’s Remarks (08:00-08:05) David Lester
08:05:00 Studying Fracture Healing - The Use of Bioimaging for Recombinant Human Bone Morphogenetic Protein-2 (Rhbmp-2) Studies (08:05-08:35) Alex Valentin
08:35:00 Use of Imaging in Support of Tailored Therapeutics (08:35-09:05) Loretta McQuaid
09:05:00 PET Receptor Occupancy - Accelerating Drug Development by Non-Invasive Measurement of Drug Action Early in the Development Pipeline (09:05-09:35) Robert A. Comley
09:35:00 Technology Workshop (Sponsorship Available) (09:35-09:50)
09:50:00 Poster Session, Exhibit Viewing, and Coffee Break (09:50-10:30)
10:30:00 The Use of Cardiovascular Imaging in Drug Development: From Preclinical to Diagnostic Applications (10:30-11:00) David Lester
11:00:00 Circulating Oncoproteins as Cancer Biomarkers for Targeted Therapies (11:00-11:30) Walter P. Carney
11:30:00 The 21-Gene Oncotype DX Breast Cancer Assay: Clinical Validation and Application (11:30-12:00) Audrey Goddard
12:00:00 Luncheon Workshop (Sponsorship Available) or Lunch on Your Own (12:00-13:30)
13:30:00 Close of Innovations in Clinical Trials: Implementation of Biomarkers Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.